398 related articles for article (PubMed ID: 18177500)
1. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.
Hartley JW; Evans LH; Green KY; Naghashfar Z; Macias AR; Zerfas PM; Ward JM
Retrovirology; 2008 Jan; 5():1. PubMed ID: 18177500
[TBL] [Abstract][Full Text] [Related]
2. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
3. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
[TBL] [Abstract][Full Text] [Related]
4. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
5. Abelson murine leukemia virus: effect of helper virus from regressing Friend virus on leukemia development.
Hines DL; Gragowski L
Leuk Res; 1983; 7(2):251-60. PubMed ID: 6304429
[TBL] [Abstract][Full Text] [Related]
6. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
8. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
Belli B; Patel A; Fan H
J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
[TBL] [Abstract][Full Text] [Related]
9. Identification of directly infected cells in the bone marrow of neonatal moloney murine leukemia virus-infected mice by use of a moloney murine leukemia virus-based vector.
Okimoto MA; Fan H
J Virol; 1999 Feb; 73(2):1617-23. PubMed ID: 9882368
[TBL] [Abstract][Full Text] [Related]
10. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
Lavignon M; Evans L
J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
[TBL] [Abstract][Full Text] [Related]
11. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
Traister RS; Lynch WP
Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
[TBL] [Abstract][Full Text] [Related]
12. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
13. Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group.
Prassolov V; Hein S; Ziegler M; Ivanov D; Münk C; Löhler J; Stocking C
J Virol; 2001 May; 75(10):4490-8. PubMed ID: 11312319
[TBL] [Abstract][Full Text] [Related]
14. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus.
Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
J Virol; 1995 Jan; 69(1):308-19. PubMed ID: 7983723
[TBL] [Abstract][Full Text] [Related]
15. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas.
Poirier Y; Jolicoeur P
J Virol; 1989 May; 63(5):2088-98. PubMed ID: 2539505
[TBL] [Abstract][Full Text] [Related]
16. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
17. In vivo interactions of ecotropic and polytropic murine leukemia viruses in mixed retrovirus infections.
Evans LH; Lavignon M; Peterson K; Hasenkrug K; Robertson S; Malik F; Virtaneva K
J Virol; 2006 May; 80(10):4748-57. PubMed ID: 16641268
[TBL] [Abstract][Full Text] [Related]
18. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
Lander JK; Chesebro B; Fan H
J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
[TBL] [Abstract][Full Text] [Related]
19. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
[TBL] [Abstract][Full Text] [Related]
20. Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus.
Green PL; Kaehler DA; Risser R
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5932-6. PubMed ID: 3039515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]